On the other hand, in human glioma and breast and prostate cancer, NRP1 expression correlates with higher tumor grade and worse prognosis 14, 15, 16, and in oral squamous carcinoma, NRP1 expression has been correlated with poor prognosis and disease relapse 17. This evidence concerns the gene NRP1 and prostate carcinoma.